Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
about
Evaluation of docking performance in a blinded virtual screening of fragment-like trypsin inhibitors.Evolutions in fragment-based drug design: the deconstruction-reconstruction approachSite Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug designMedicinal chemistry for 2020Vemurafenib in melanoma.Computational medicinal chemistry: part II.
P2860
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
@en
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
@nl
type
label
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
@en
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
@nl
prefLabel
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
@en
Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
@nl
P2860
P356
P1476
Computational medicinal chemistry in fragment-based drug discovery: what, how and when
@en
P2093
Manuel Urbano-Cuadrado
P2860
P304
P356
10.4155/FMC.10.277
P577
2011-01-01T00:00:00Z